Pharmaceutical Technology

Pharmaceutical Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X

Advertise with us

Suppliers / Active Pharmaceutical Ingredients and Intermediates

# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials

After Zavante deal, Nabriva is poised to launch two first-in-class antibiotics

Fasinumab Phase III osteoarthritis trial meets endpoints

EMA gives PRIME status to promising Huntington’s treatment

Cold Chain

EMA gives PRIME status to promising Huntington’s treatment

UK seeks harmony with EU CTR as NHS and pharma stockpile drugs

Pharma air freight: what does it take to get certified?

Diseases

NUI Galway finds new treatment strategy for breast cancer relapse

BioNTech signs $425m flu vaccine deal with Pfizer

RXi and Karolinska Institutet target solid tumour therapy

Drug Development

So you want to break into the Chinese vaccine market?

Revlimid demonstrates positive phase III results in Indolent NHL

Fasinumab Phase III osteoarthritis trial meets endpoints

Manufacturing

So you want to break into the Chinese vaccine market?

After Zavante deal, Nabriva is poised to launch two first-in-class antibiotics

Big soil: Genentech and Lodo launch $1bn project to develop new drugs from earth

Market Data

So you want to break into the Chinese vaccine market?

Revlimid demonstrates positive phase III results in Indolent NHL

Deals and M&As this week: Aralez Pharmaceuticals, Perrigo, Takeda

Obsessions

Hackers can fool doctors with fake vital signs, but only the rich and powerful need to worry

Human-level intelligent machines will arrive in a decade: Technology industry veteran

UK attempts to plug STEM skills shortage with science visa scheme